Literature DB >> 9651058

Characterization of primary intracranial lymphoma by computed tomography: an analysis of 36 cases and a review of the literature with particular reference to calcification haemorrhage and cyst formation.

C N Jenkins1, I R Colquhoun.   

Abstract

Previous published series describing the appearances of primary central nervous system lymphoma (PCNSL) state that calcification, haemorrhage and cyst formation are rare, but generally fail to quantify or expand on this statement. We present the pre-treatment computed tomography (CT) findings of 36 patients with biopsy proven PCNSL. In this series, calcification was present in only one very atypical lesion and evidence of haemorrhage was not seen. Small intralesional cysts were present in four of the total of 50 lesions. PCNSL usually appeared as one or more well defined focal lesions, iso- or hyperdense to grey matter, with homogeneous enhancement following IV contrast injection. Less commonly the contrast enhancement was inhomogeneous, only one lesion failed to enhance. Disproportionately little oedema and mass effect compared with lesion size was noted on approximately half the CTs. Lesions usually touch either the ependymal lining of the ventricles or the leptomeningeal surface.

Entities:  

Mesh:

Year:  1998        PMID: 9651058     DOI: 10.1016/s0009-9260(98)80271-7

Source DB:  PubMed          Journal:  Clin Radiol        ISSN: 0009-9260            Impact factor:   2.350


  9 in total

1.  Multiple calcified primary central nervous system lymphoma with immunodeficiency in a child.

Authors:  Jing-Qi Zhu; Nan-Xin Hao; Wei-Qun Bao; Xiang-Ru Wu
Journal:  World J Pediatr       Date:  2011-06-01       Impact factor: 2.764

2.  MRI findings of primary CNS lymphoma in 26 immunocompetent patients.

Authors:  Dong Zhang; Liang-Bo Hu; Tobias D Henning; Elisabeth M Ravarani; Li-Guang Zou; Xiao-Yuan Feng; Wen-Xian Wang; Li Wen
Journal:  Korean J Radiol       Date:  2010-04-29       Impact factor: 3.500

3.  Coexistence of primary central nervous system lymphoma and primary breast lymphoma: Clinical presentation, imaging features, and treatment management.

Authors:  Francesca Di Giuliano; Tommaso Perretta; Francesca Pitocchi; Noemi Pucci; Maria Lina Serio; Aurelia Caliandro; Eliseo Picchi; Valentina Ferrazzoli; Chiara Adriana Pistolese; Francesco Garaci; Roberto Floris
Journal:  Radiol Case Rep       Date:  2022-05-09

4.  Hemorrhage and VEGF expression in a case of primary CNS lymphoma.

Authors:  James Rubenstein; Nancy Fischbein; Ken Aldape; Eric Burton; Marc Shuman
Journal:  J Neurooncol       Date:  2002-05       Impact factor: 4.130

Review 5.  Multimodality imaging of primary CNS lymphoma in immunocompetent patients.

Authors:  S Partovi; S Karimi; J K Lyo; A Esmaeili; J Tan; L M Deangelis
Journal:  Br J Radiol       Date:  2014-04       Impact factor: 3.039

6.  Multifocal hemosiderin depositions on T2*-weighted magnetic resonance imaging in a patient with pathology-proven systemic diffuse large B-cell lymphoma.

Authors:  Xun-zhe Yang; Jun Ni; Li-ying Cui
Journal:  BMC Neurol       Date:  2014-09-25       Impact factor: 2.474

7.  Primary central nervous system lymphoma: is absence of intratumoral hemorrhage a characteristic finding on MRI?

Authors:  Akihiko Sakata; Tomohisa Okada; Akira Yamamoto; Mitsunori Kanagaki; Yasutaka Fushimi; Toshiki Dodo; Yoshiki Arakawa; Jun C Takahashi; Susumu Miyamoto; Kaori Togashi
Journal:  Radiol Oncol       Date:  2015-03-25       Impact factor: 2.991

8.  Differentiation of primary central nervous system lymphoma from glioblastoma using optical coherence tomography based on attention ResNet.

Authors:  Sanford P C Hsu; Tien-Yu Hsiao; Li-Chieh Pai; Chia-Wei Sun
Journal:  Neurophotonics       Date:  2022-03-23       Impact factor: 4.212

9.  Delayed Contrast Enhancement in Magnetic Resonance Imaging and Vascular Morphology of Primary Diffuse Large B-Cell Lymphoma (DLBCL) of the Central Nervous System (CNS): A Retrospective Study.

Authors:  Dandan Liu; Xiaojun Liu; Zhaogui Ba; Limei Xie; Jiwu Han; Dexin Yu; Xiangxing Ma
Journal:  Med Sci Monit       Date:  2019-05-05
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.